Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

149.90 +0.78 (+0.52%)
Streaming Delayed Price Updated: 3:36 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,861,735
Open 149.86
Bid (Size) 149.89 (2)
Ask (Size) 149.90 (2)
Prev. Close 149.12
Today's Range 148.20 - 150.49
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.18%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
The company is establishing its line-up of drugs behind bread-and-butter med Ingrezza. 
Via Investor's Business Daily
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
From Johnson & Johnson
Via Business Wire

Performance

YTD
-6.30%
-6.30%
1 Month
-3.43%
-3.43%
3 Month
-7.74%
-7.74%
6 Month
-0.99%
-0.99%
1 Year
-8.42%
-8.42%

More News

Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
From Brodsky & Smith LLC
Via GlobeNewswire
Unpacking the Latest Options Trading Trends in Johnson & Johnson
Via Benzinga
3 Dividend Stocks to Buy Now for Lifelong Income
Via InvestorPlace
5 Crash-Proof Stocks to Buy Immediately
Via InvestorPlace
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
Via InvestorPlace
MarketBeat Week in Review – 4/15 - 4/19
Via MarketBeat
Topics Economy
Exposures Interest Rates
Investing for the Long-Term: 3 Stocks With Proven Track Records
Via InvestorPlace
Topics Economy
Exposures Economy
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
Via InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
Via Benzinga
Topics Brexit
Exposures Brexit
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Via Benzinga
Exposures Product Safety
Top Stock Reports For Nvidia, Alphabet And Johnson & Johnson
Via Talk Markets
Recession-Proof Riches: 3 Stocks That Thrive in Any Economy
Via InvestorPlace
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
Via InvestorPlace
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
Via Benzinga
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
Via Benzinga
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Put $10,000 in These 3 Dividend Stocks by 2025
Via InvestorPlace
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Via MarketBeat
Topics Economy
Exposures COVID-19 Supply Chain
Why Johnson & Johnson Stock Got Tossed by the Market Today
Via The Motley Fool
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.